I now have all the key information needed. Let me compile a comprehensive answer.
Drugs Causing Hemolysis
Drug-induced hemolysis occurs through several distinct mechanisms. Understanding which mechanism a drug uses helps predict the clinical presentation and guides management.
1. Immune-Mediated Mechanisms
A. Hapten (Drug Adsorption) Mechanism
The drug binds firmly to the RBC membrane, creating a new antigenic determinant that triggers antibody formation. Hemolysis follows 1-2 weeks after initiating therapy and usually requires large intravenous doses.
Prototype drugs:
- Penicillin (classic example - high-dose IV)
- Cephalosporins (2nd and 3rd generation especially)
The resulting antibodies sometimes fix complement, causing intravascular hemolysis, but more often act as opsonins producing extravascular hemolysis in the spleen (spherocytes, positive direct Coombs test).
B. Immune Complex (Innocent Bystander) Mechanism
The drug-antibody immune complex deposits on the RBC surface and activates complement, lysing the cell. The RBC is an "innocent bystander."
Drugs:
- Quinine / Quinidine (classic)
- NSAIDs
- Stibophen
C. Tolerance-Breaking (Autoantibody) Mechanism
The drug breaks self-tolerance and triggers true autoantibody formation against native RBC antigens (especially Rh blood group antigens), even after the drug is stopped.
Prototype drug:
- Alpha-methyldopa (~10% of patients develop a positive direct Coombs test; ~1% develop clinically significant hemolysis)
Other drugs with similar mechanism:
- Levodopa, mefenamic acid, procainamide
Source: Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 607
2. G6PD Deficiency-Related (Oxidative) Hemolysis
In G6PD-deficient individuals, certain drugs cause oxidative damage to RBCs, forming Heinz bodies and triggering acute hemolysis. Older RBCs are preferentially destroyed (self-limited course). The reticulocyte surge during recovery can falsely normalize G6PD enzyme levels.
Drugs with definite/predictable hemolysis in G6PD deficiency:
| Category | Drug |
|---|
| Antimalarials | Primaquine, Pamaquine, Dapsone-containing combinations |
| Antiseptics / Dyes | Methylene blue (methylthioninium chloride), Toluidine blue |
| Urinary | Phenazopyridine, Nitrofurantoin |
| Uricolytics | Rasburicase, Pegloticase |
Drugs with possible hemolysis in G6PD deficiency:
- Chloroquine, Quinine, Quinidine, Mepacrine
- Aspirin (at high doses), Phenacetin
- Probenecid, Dimercaprol (BAL)
- Vitamin K analogues (water-soluble)
Source: Tietz Textbook of Laboratory Medicine, 7th Edition, Table 78.3; Tintinalli's Emergency Medicine
3. Most Commonly Implicated Drugs (Overall Summary)
The Washington Manual lists the most common offenders as:
- Cephalosporins
- Penicillins
- NSAIDs
- Quinine / Quinidine
Source: Washington Manual of Medical Therapeutics
4. Microangiopathic Hemolysis (Drug-Induced TTP/HUS)
Some drugs cause hemolysis indirectly by inducing TMA (thrombotic microangiopathy), producing fragmented RBCs (schistocytes):
- Cyclosporine, Tacrolimus
- Quinine (can also cause TTP)
- Mitomycin C, Gemcitabine
- Oral contraceptives (rare)
5. Diagnosis and Management
| Step | Action |
|---|
| Labs | LDH ↑, Haptoglobin ↓, Indirect bilirubin ↑, Reticulocytosis |
| Smear | Spherocytes (immune), schistocytes (MAHA), Heinz bodies (G6PD/oxidative) |
| Coombs | Direct antiglobulin test (positive in immune-mediated) |
| Treatment | Stop the offending drug (most important step) |
| Adjuncts | Corticosteroids if severe; transfusion with screened RBCs; IV fluids to protect kidneys |
| G6PD-specific | Treat infections aggressively; avoid oxidant drugs; full recovery is typical |
Source: Tintinalli's Emergency Medicine, Washington Manual of Medical Therapeutics, Robbins & Cotran
Quick memory aid - drugs causing immune hemolysis:
- Hapten: Penicillin, Cephalosporins
- Immune complex: Quinine, NSAIDs
- Autoantibody: Alpha-methyldopa
- Oxidative (G6PD): Primaquine, Dapsone, Nitrofurantoin, Phenazopyridine, Methylene blue, Rasburicase